Alkem launches India’s first ready-to-use semaglutide syringe for diabetes and weight loss from ₹350

The launch comes as India grapples with rising diabetes and obesity cases, offering patients another treatment option designed to improve long-term adherence.

Leave a Reply

Your email address will not be published. Required fields are marked *